To access this element change to forms mode OFF
Grant Award View - GA214900
Development of a non-invasive mucosal integrity diagnostic and...
GA ID:
GA214900
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
21-Nov-2021
Publish Date:
24-Jan-2022
Category:
Health and Medical Research
Grant Term:
1-Jan-2022 to 31-Jan-2025
Value (AUD):
$349,437.27
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Development Grants
Grant Activity:
Development of a non-invasive mucosal integrity diagnostic and ingestible capsule sampling tool targeting IBD gut health.
Purpose:
Inflammatory Bowel Disease (IBD) affects many Australians and is a chronic condition requiring life-long management and intervention. Current technologies to manage the disease include invasive colonoscopy or non-specific lab tests. There is a need for non-invasive methods to improve the health and well-being of people suffering from IBD. We wish to develop a non-invasive diagnostic and ingestible sampling capsule that can determine gut-health and guide treatment for the long-term patients.
GO ID:
GO Title:
NHMRC Development Grants 2021 for funding in 2022
Internal Reference ID:
2021/GNT2014168
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, UNITED STATES